Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study
Sponsor: University of Edinburgh
Summary
FutureMS is a project created in direct response to frequent questions people with MS ask their doctors. Every person newly diagnosed wants to know how MS will affect them over their life and what can be done to stop the disease progressing and improve their quality of life. FutureMS aims to help answer those questions. The original FutureMS study provided a snapshot of the impact of MS within a year of diagnosis. However, MS is a long-term condition and so the investigators now want to better understand the impact of MS, on the same individuals, after approximately 5 and 10 years of living with MS. This is the purpose of FutureMS-2.
Official title: FutureMS-2: Clinical, Laboratory, and Genomic Predictors of Disease Activity in People Diagnosed With Relapsing Onset Multiple Sclerosis: an Observational Cohort and Scottish Precision Medicine Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
440
Start Date
2021-10-07
Completion Date
2029-09
Last Updated
2025-05-11
Healthy Volunteers
No
Conditions
Locations (5)
Aberdeen Clinical Research Facility Royal Cornhill Hospital
Aberdeen, United Kingdom
Dundee Clinical Research Centre Ninewells Hospital
Dundee, United Kingdom
Anne Rowling Regenerative Neurology Clinic
Edinburgh, United Kingdom
Glasgow Clinical Research Facility Queen Elizabeth University Hospital
Glasgow, United Kingdom
Centre for Health Sciences Raigmore Hospital
Inverness, United Kingdom